Expertise in
5
conditions

Sanjeewa S. Wickremasinghe

32 Gisborne Street, 
East Melbourne, VIC, AU 
Expertise in
5
conditions
32 Gisborne Street, 
East Melbourne, VIC, AU 

Overview

Sanjeewa Wickremasinghe practices practicing medicine in East Melbourne, Australia.

Wickremasinghe is highly rated in 5 conditions, according to our data. Their clinical expertise encompasses Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Cataract Removal, and Iridectomy.

They are actively involved in clinical research, co-authoring 39 peer reviewed articles and participating in 1 clinical trial.

Locations

32 Gisborne Street, East Melbourne, VIC 3002, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomised, Double-Masked Vehicle-Controlled, Multiple Dose, Dose Escalation Study To Evaluate The Safety and Tolerability of EXN407 in Subjects With Centre Involved Diabetic Macular Oedema Secondary to Diabetes Mellitus
A Randomised, Double-Masked Vehicle-Controlled, Multiple Dose, Dose Escalation Study To Evaluate The Safety and Tolerability of EXN407 in Subjects With Centre Involved Diabetic Macular Oedema Secondary to Diabetes Mellitus
Enrollment Status: Completed
Publish Date: May 09, 2025
Intervention Type: Drug
Study Drug: EXN407
Study Phase: Phase 1/Phase 2

39 Total Publications

Switching to Faricimab or High-Dose Aflibercept for Neovascular AMD in High-Demand Patients: Impact on Injection Interval in a Real-World Cohort.
Switching to Faricimab or High-Dose Aflibercept for Neovascular AMD in High-Demand Patients: Impact on Injection Interval in a Real-World Cohort.
Journal: Clinical & experimental ophthalmology
Published: January 03, 2026

Frequently Asked Questions about Sanjeewa S. Wickremasinghe

Is Sanjeewa S. Wickremasinghe a top-rated expert for Diabetic Macular Edema (DME)?

MediFind is an objective health platform that identifies experts based on real-world data. Sanjeewa S. Wickremasinghe is classified as an Distinguished expert for Diabetic Macular Edema (DME), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Sanjeewa S. Wickremasinghe participate in research or clinical trials?

Yes. Sanjeewa S. Wickremasinghe has published 39 articles and abstracts on conditions like Diabetic Macular Edema (DME). You can view a list of Sanjeewa S. Wickremasinghe's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Wickremasinghe's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile